Ted C. Nark
Director · Amneal Pharmaceuticals, Inc.
- 2025
- May 8, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ted C. Nark files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- John Kiely - $882K in AMRX purchases and sales in the last 12 months
- Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ted C. Nark?
Ted C. Nark is a corporate insider, tracked as Director of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ted C. Nark last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 2 filings going back to 2025.
Has Ted C. Nark been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($586K) across all tracked filings.
